Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert Mulroy Insider Profile
4 Followers
Robert Mulroy, President & CEO, Director at Merrimack Pharmaceuticals, holds 1.51M shares in Merrimack Pharmaceuticals (Ticker: MACK).
Robert Mulroy Merrimack Pharmaceuticals (MACK)President & CEO, Director
Merrimack Pharmaceuticals (MACK)
President & CEO, Director
Ranked #16,288 out of 98,909 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+49.10%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that Robert Mulroy holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 07, 2014 - May 07, 2015
Return:+65.10%
The most profitable trade made by Robert Mulroy
Robert Mulroy's Trading History
List of latest transactions for each holding click on a transaction to see Robert Mulroy's performance on stock
You May Also Like
Robert Mulroy insider profile FAQ
What is the percentage of profitable transactions made by Robert Mulroy?
The percentage of profitable transactions made by Robert Mulroy is 100%.
What is the average return per transaction made by Robert Mulroy?
The average return per transaction made by Robert Mulroy is 49.10%.
What stocks does Robert Mulroy hold?
Robert Mulroy holds: MACK stocks.
What was Robert Mulroy’s latest transaction?
Robert Mulroy latest transaction was an Uninformative Sell of $1.34M.
What was Robert Mulroy's most profitable transaction?
Robert Mulroy’s most profitable transaction was an Informative Buy of MACK stock on May 7, 2014. The return on the trade was 65.10%.
What is Robert Mulroy's role in Merrimack Pharmaceuticals?
Robert Mulroy's role in Merrimack Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.